5,077
Views
1
CrossRef citations to date
0
Altmetric
Editorial

High levels of anti-Müllerian hormone: what does this mean for IVF treatment?

&
Pages 209-211 | Published online: 10 Jan 2014

References

  • Dewailly D, Gronier H, Poncelet E et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum. Reprod. 26(11), 3123–3129 (2011).
  • Tehrani FR, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum anti-Müllerian hormone concentration. Menopause 18(7), 766–770 (2011).
  • La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, Volpe A. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil. Steril. 85(5), 1547–1549 (2006).
  • Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril. 51(4), 651–654 (1989).
  • Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction. Hum. Reprod. 24(11), 2755–2759 (2009).
  • Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum. Reprod. 12(2), 220–223 (1997).
  • Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil. Steril. 90(5), 1656–1661 (2008).
  • Anderson RA, Nelson SM, Wallace WH. Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas 71(1), 28–33 (2012).
  • Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum. Reprod. 20(4), 923–927 (2005).
  • La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Müllerian hormone throughout the human menstrual cycle. Hum. Reprod. 21(12), 3103–3107 (2006).
  • Broer SL, Mol B, Dólleman M, Fauser BC, Broekmans FJ. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr. Opin. Obstet. Gynecol. 22(3), 193–201 (2010).
  • Biasoni V, Patriarca A, Dalmasso P et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod. Biol. Endocrinol. 9, 112 (2011).
  • Brodin T. Ovarian reserve and assisted reproduction. Acta Universitatis Upsaliensis, Uppsala, Sweden, 88 (2013).
  • Nelson SM, Yates RW, Lyall H et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum. Reprod. 24(4), 867–875 (2009).
  • Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum. Reprod. Update 12(2), 159–168 (2006).
  • Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum. Reprod. 24(10), 2389–2394 (2009).
  • Nelson SM, Yates RW, Fleming R. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles – implications for individualization of therapy. Hum. Reprod. 22(9), 2414–2421 (2007).
  • Holte J, Brodin T, Berglund L, Hadziosmanovic N, Olovsson M, Bergh T. Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries. Fertil. Steril. 96(3), 594–599 (2011).
  • Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Anti-Müllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J. Clin. Endocrinol. Metab. 98(3), 1107–1114 (2013).
  • Steiner AZ, Herring AH, Kesner JS et al. Anti-Müllerian hormone as a predictor of natural fecundability in women aged 30–42 years. Obstet. Gynecol. 117(4), 798–804 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.